Carcinoid patients are diagnosed biochemically on the basis of increased urinary excretion of 5-hydroxyindoleacetic
acid (5-HIAA); urinary and platelet
serotonin concentrations are considered to provide complementary information. Using established HPLC methods with fluorometric detection, we evaluated the clinical usefulness of measurements of urinary
5-HIAA and urinary, plasma, and platelet
serotonin in 30 consecutive patients with histologically proven
carcinoid tumors of fore-, mid-, and hindgut origin before treatment. Ten patients showed no signs of
serotonin overproduction; 14 had increased concentrations of urinary
5-HIAA and platelet
serotonin; and platelet
serotonin, but not urinary
5-HIAA, was increased in 6. None had increased urinary
5-HIAA excretion without an increase in platelet
serotonin content. In cases with high rates of
tumor serotonin secretion, platelet
serotonin reached a maximum and did not correlate with
serotonin secretion rate, whereas urinary
5-HIAA was correlated. Increased platelet
serotonin was correlated with increased plasma
serotonin and with occurrence of
carcinoid syndrome. Increased urinary
serotonin, allegedly caused by increases in circulating
5-hydroxytryptophan, almost invariably coincided with increased platelet
serotonin, but not necessarily with above-normal urinary
5-HIAA excretion. From these results and long-term monitoring of three patients during treatment, we conclude that platelet
serotonin is more sensitive than urinary
5-HIAA for detecting
carcinoids that secrete only small amounts of
serotonin.